Successful conservative approach to covid 19 with extensive splanchnic circulation thrombosis

The novel 2019 coronavirus disease (COVID-19), which is caused by infection with the severe acute respiratory syndrome corona­virus 2 (SARS-CoV-2), was first reported in Wuhan, China, in December 2019 . Since that time, the COVID-19 pandemic has spread rapidly around the world in an exponential fashion and has caused many deaths.  Preliminary data have reported an increased risk of venous thromboembolism and acute myocardial infarctions, most likely caused by excessive inflammation, platelet activation, endothelial dysfunction, and stasis.The high mortality and its relationship with thromboembolic diseases in COVID-19 have increasingly attracted attention . D-dimer has been repeatedly reported to be a useful biomarker associated with the severity of disease and is a predictor of adverse outcomes . The high incidence of venous thromboembolism (VTE) and the importance of giving anticoagulant thromboprophylaxis is stated in guidance documents and supported by consecutive autopsy findings noting frequent deep vein thrombosis in 7 of 12 COVID-19 patients (58%) with complicating pulmonary embolism in 4 patients (33%) . An increased incidence of arterial thromboses such as stroke and acute coronary syndromes has also been reported in COVID-19 . The effectiveness of prophylactic and therapeutic anticoagulant use in this context is controversial.Hereby we are reporting a case of covid 19 with extensive splanchnic circulation thrombosis presented to Narayana hospital, Mysore, managed successfully with conservative approach without any surgical intervention